Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Rathke Nora |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Doddapattar, PK; Aflaki, E; Radovic, B; Rathke, N; Gruenberger, RB; Kratky, D REDUCED ATHEROSCLEROTIC PLAQUE FORMATION IN APOE-/- MICE LACKING PERILIPIN
ATHEROSCLEROSIS SUPP. 2011; 12(1): 31-31. Doi: 10.1016/S1567-5688(11)70137-4
Web of Science FullText FullText_MUG

 

Buchebner, M; Pfeifer, T; Rathke, N; Chandak, PG; Kratzer, A; Haemmerle, G; Zechner, R; Cravatt, B; Kratky, D Comparison of HSL and KIAA1363: two potential cholesteryl ester hydrolases in mouse peritoneal macrophages
16 Annual meeting of the Austrian Atheroscerosis Society; May 8-9, 2009; St. Gilgen, Austria. 2009. [Oral Communication]

 

Buchebner, M; Pfeifer, T; Rathke, N; Chandak, PG; Kratzer, A; Haemmerle, G; Zechner, R; Cravatt, B; Kratky, D Comparison of HSL and KIAA1363: two potential cholesteryl ester hydrolases in mouse peritoneal macrophages
Frontier Lipidology:Lipidomics in Health and Disease; May 10-13, ; Gothenburg, Sweden. 2009. [Poster]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
15. Austrian Ateriosclerosis Society Annual Meeting; 18. – 19. April 2008; St.Gilgen, Austria. 2008. [Oral Communication]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
2nd International Graz Symposium on Lipid and Membrane Biology: Focus on Lipotoxicity ; March 13-15; Graz, Austria. 2008. [Poster]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
14th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE; June 11-14, 2008; Humlebaek, Denmark. 2008. [Oral Communication]

 

Kratzer, A; Buchebner, M; Becker, TM; Pfeifer, T; Uray, G; Ebner, B; Rathke, N; Ahammer, H; Trauner, M; Hoefler, G; Levak-Frank, S; Levi, M; Kostner, GM; Kratky, D Partial LXR agonist reduces atherosclerosis in ApoE-deficient mice without inducing liver steatosis and hypertriglyceridemia
Experimental Biology 2008 (ASBMB); April 5-9, 2008; San Diego, USA. 2008. [Poster]

 

Kratzer, A; Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D Synthetic LXR agonist reduces atherosclerotic plaque formation in ApoE deficient mice without inducing liver steatosis and hypertriglyceridemia
OEGBM meeting 22th to 24th September 2008, Graz, Austria; SEPT 22-24, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Kratzer, B; Ebner, T. Becker, E. Calayir, C. Guelly, M. Buchebner, T. Pfeifer, N. Rathke, S. Levak-Frank, N. Barry, T. Jiang, X. Wang, N. Zelcer, P. Tontonoz, M. Levi, G.M. Kostner, D. Kratky Novel Effects of Liver X Receptor (LXR) agonist N,N-Dimethyl-3â-hydroxycholenic acid (DMHCA) on the gene regulation and morphology of mouse peritoneal macrophages
Keystone symposium on nuclear receptors: orphan brothers and steroid sisters ; APRIL 30-May 4, 2008 ; Whistler, Canada. 2008. [Poster]

 

Buchebner, M; Rathke, N; Ebner, B; Kratzer, A; Kostner, GM; Levak-Frank, S; Kratky, D. Differences in gender-specific gene expression in murine macrophages and foam cells.
Meeting of the Austrian Atherosclerosis Society; May 11-12, 2007; St. Gilgen, Austria. 2007. [Oral Communication]

 

Panzenboeck, U; Kratzer, I; Rathke, N; Wintersperger, A; Reicher, H; Bernhart, E; Hammer, A; Sattler, W LXR activation regulates target genes involved in cholesterol turnover at the blood-brain barrier
3rd Lipidomics Meeting ‘From Lipid Analysis to Genetic Disorders’; MAY 10-12, 2006; Marseille, FRANCE. 2006. [Poster]

 

Rathke, N; Wintersperger, A; Kratzer, I; Reicher, H; Bernhart, E; Schmitz, G; Sattler, W; Panzenboeck, U A potential role for apoA-I binding protein (AI-BP) in cholesterol recycling at the blood-brain barrier.
13. Jahrestagung der Österreichischen Atherosklerosegesellschaft (AAS); Mai 5-6, 2006; St. Gilgen, AUSTRIA. 2006. [Oral Communication]

 

© Med Uni Graz Impressum